An Investigational Immuno-therapy Study of Nivolumab Combined With Ipilimumab Compared to Nivolumab by Itself After Complete Surgical Removal of Stage IIIb/c/d or Stage IV Melanoma
Public ClinicalTrials.gov record NCT03068455. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized Study of Adjuvant Immunotherapy With Nivolumab Combined With Ipilimumab Versus Nivolumab Monotherapy After Complete Resection of Stage IIIb/c/d or Stage IV Melanoma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine whether an investigational immunotherapy Nivolumab, when combined with Ipilimumab, is more effective than Nivolumab by itself, in delaying the return of cancer in patients who have had a complete surgical removal of stage IIIb/c/d or stage IV Melanoma
Study identification
- NCT ID
- NCT03068455
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,844 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 11, 2017 (Actual)
- Primary completion
- Jun 12, 2020 (Actual)
- Completion
- Feb 2, 2021 (Actual)
- Last update posted
- Sep 20, 2021
2017 – 2021
United States locations
- U.S. sites
- 33
- U.S. states
- 20
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Arizona Cancer Center | Tucson | Arizona | 85724 | — |
| The Angeles Clinic & Research Institute | Los Angeles | California | 90025 | — |
| California Pacific Medical Center | San Francisco | California | 94115 | — |
| University Of Colorado | Aurora | Colorado | 80045 | — |
| Georgetown University Med Ctr | Washington D.C. | District of Columbia | 20007 | — |
| Mount Sinai Comprehensive Cancer Center | Miami Beach | Florida | 33140 | — |
| UF Health Cancer Center at Orlando Health | Orlando | Florida | 32806 | — |
| H. Lee Moffitt Cancer Center | Tampa | Florida | 33612 | — |
| Winship Cancer Institute | Atlanta | Georgia | 30322 | — |
| University Of Chicago | Chicago | Illinois | 19123 | — |
| Northwestern University | Chicago | Illinois | 60611 | — |
| Oncology Specialists, S.C. | Park Ridge | Illinois | 60068 | — |
| Mass General Hospital | Boston | Massachusetts | 02114 | — |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | — |
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02215 | — |
| University Of Michigan Health System | Ann Arbor | Michigan | 48109-5848 | — |
| Virginia Piper Cancer Institute | Minneapolis | Minnesota | 55407 | — |
| Mayo Clinic Rochester | Rochester | Minnesota | 55905 | — |
| Washington University School Of Medicine | St Louis | Missouri | 63110 | — |
| NYU Langone Medical Center | New York | New York | 10016 | — |
| Memorial Sloan Kettering Nassau | New York | New York | 10065 | — |
| Carolinas Med Ctr | Charlotte | North Carolina | 28204 | — |
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
| Providence Cancer Center Oncology And Hematology Care | Portland | Oregon | 97213 | — |
| Oregon Health & Science University | Portland | Oregon | 97239 | — |
| St. Luke's University Health Network | Easton | Pennsylvania | 18045 | — |
| Local Institution | Nashville | Tennessee | 37232 | — |
| Texas Oncology Sammons Cancer Center | Dallas | Texas | 75246 | — |
| Md Anderson Can Cnt | Houston | Texas | 77030-4009 | — |
| Huntsman Cancer Institute | Salt Lake City | Utah | 84112 | — |
| University Of Virginia Health System | Charlottesville | Virginia | 22908 | — |
| Inova Melanoma and Skin Cancer Center | Fairfax | Virginia | 55905 | — |
| University Of Washington Cancer Care Alliance | Seattle | Washington | 98109-1023 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 91 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03068455, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 20, 2021 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03068455 live on ClinicalTrials.gov.